Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

The Lancet Oncology(2023)

引用 9|浏览60
暂无评分
摘要
Zymeworks, Jazz, and BeiGene.
更多
查看译文
关键词
metastatic biliary tract cancer,herizon-btc,single-arm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要